[HTML][HTML] Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Y Li, Y Liu, H Xu, G Jiang, K Van der Jeught… - Nature …, 2018 - nature.com
Heterozygous deletion of chromosome 17p (17p) is one of the most frequent genomic
events in human cancers. Beyond the tumor suppressor TP53, the POLR2A gene encoding …

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Y Li, Y Liu, H Xu, G Jiang… - Nature …, 2018 - ohiostate.elsevierpure.com
Heterozygous deletion of chromosome 17p (17p) is one of the most frequent genomic
events in human cancers. Beyond the tumor suppressor TP53, the POLR2A gene encoding …

[PDF][PDF] Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Y Li, Y Liu, H Xu, G Jiang… - NATURE …, 2018 - xiongbinlulab.org
Heterozygous deletion of chromosome 17p (17p) is one of the most frequent genomic
events in human cancers. Beyond the tumor suppressor TP53, the POLR2A gene encoding …

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Y Li, Y Liu, H Xu, G Jiang… - Nature …, 2018 - econpapers.repec.org
Heterozygous deletion of chromosome 17p (17p) is one of the most frequent genomic
events in human cancers. Beyond the tumor suppressor TP53, the POLR2A gene encoding …

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Y Li, Y Liu, H Xu, G Jiang, K Van der Jeught… - Nature …, 2018 - experts.umn.edu
Heterozygous deletion of chromosome 17p (17p) is one of the most frequent genomic
events in human cancers. Beyond the tumor suppressor TP53, the POLR2A gene encoding …

[PDF][PDF] Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Y Li, Y Liu, H Xu, G Jiang, K Van der Jeught… - NATURE …, 2018 - core.ac.uk
Heterozygous deletion of chromosome 17p (17p) is one of the most frequent genomic
events in human cancers. Beyond the tumor suppressor TP53, the POLR2A gene encoding …

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Y Li, Y Liu, H Xu, G Jiang… - Nature …, 2018 - mdanderson.elsevierpure.com
Heterozygous deletion of chromosome 17p (17p) is one of the most frequent genomic
events in human cancers. Beyond the tumor suppressor TP53, the POLR2A gene encoding …

[引用][C] Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Y Li, Y Liu, H Xu, G Jiang, K Van der Jeught… - Nature …, 2018 - cir.nii.ac.jp
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition
of RNA polymerase II | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] …

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.

Y Li, Y Liu, H Xu, G Jiang… - Nature …, 2018 - search.ebscohost.com
Heterozygous deletion of chromosome 17p (17p) is one of the most frequent genomic
events in human cancers. Beyond the tumor suppressor TP53, the POLR2A gene encoding …

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Y Li, Y Liu, H Xu, G Jiang… - Nature …, 2018 - scholarship.miami.edu
Heterozygous deletion of chromosome 17p (17p) is one of the most frequent genomic
events in human cancers. Beyond the tumor suppressor TP53, the POLR2A gene encoding …